Dexamethasone Tablets, USPDexamethasone Oral Solution, USP and Dexamethasone Oral Solution, USP Intensol™ (Concentrate)
![Outcome of superficial keratectomy without conjunctival graft as a surgical technique for immune‐mediated keratitis in horses: Four cases - Dieterman - 2022 - Equine Veterinary Education - Wiley Online Library Outcome of superficial keratectomy without conjunctival graft as a surgical technique for immune‐mediated keratitis in horses: Four cases - Dieterman - 2022 - Equine Veterinary Education - Wiley Online Library](https://beva.onlinelibrary.wiley.com/cms/asset/adf73c87-62d6-4d74-936d-8cef7dfa0667/eve13589-fig-0002-m.jpg)
Outcome of superficial keratectomy without conjunctival graft as a surgical technique for immune‐mediated keratitis in horses: Four cases - Dieterman - 2022 - Equine Veterinary Education - Wiley Online Library
![Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study | Journal of Clinical Oncology Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study | Journal of Clinical Oncology](https://ascopubs.org/cms/10.1200/JCO.20.03143/asset/images/large/jco.20.03143t1.jpeg)
Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study | Journal of Clinical Oncology
![Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study | Journal of Clinical Oncology Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study | Journal of Clinical Oncology](https://ascopubs.org/cms/10.1200/JCO.20.03143/asset/images/large/jco.20.03143t3.jpeg)
Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study | Journal of Clinical Oncology
![Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study | Journal of Clinical Oncology Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study | Journal of Clinical Oncology](https://ascopubs.org/cms/10.1200/JCO.20.03143/asset/images/large/jco.20.03143f2.jpeg)
Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study | Journal of Clinical Oncology
![Outcome of superficial keratectomy without conjunctival graft as a surgical technique for immune‐mediated keratitis in horses: Four cases - Dieterman - 2022 - Equine Veterinary Education - Wiley Online Library Outcome of superficial keratectomy without conjunctival graft as a surgical technique for immune‐mediated keratitis in horses: Four cases - Dieterman - 2022 - Equine Veterinary Education - Wiley Online Library](https://beva.onlinelibrary.wiley.com/cms/asset/5023a8d8-8823-4efb-af86-0df4350b5d86/eve.v34.8.cover.jpg?trick=1708300029249)
Outcome of superficial keratectomy without conjunctival graft as a surgical technique for immune‐mediated keratitis in horses: Four cases - Dieterman - 2022 - Equine Veterinary Education - Wiley Online Library
![Outcome of superficial keratectomy without conjunctival graft as a surgical technique for immune‐mediated keratitis in horses: Four cases - Dieterman - 2022 - Equine Veterinary Education - Wiley Online Library Outcome of superficial keratectomy without conjunctival graft as a surgical technique for immune‐mediated keratitis in horses: Four cases - Dieterman - 2022 - Equine Veterinary Education - Wiley Online Library](https://beva.onlinelibrary.wiley.com/cms/asset/fd9ad796-c407-49d2-9894-6c8b9b344344/eve13589-fig-0005-m.jpg)
Outcome of superficial keratectomy without conjunctival graft as a surgical technique for immune‐mediated keratitis in horses: Four cases - Dieterman - 2022 - Equine Veterinary Education - Wiley Online Library
![Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment | Leukemia Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment | Leukemia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41375-020-0813-1/MediaObjects/41375_2020_813_Fig4_HTML.png)